Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1G93A mouse model

Antioxidants and Redox Signaling

Volumn 17, Issue 10, 2012, Pages 1333-1350

  Capitanio, Daniele ^a,b   Vasso, Michele ^a,b   Ratti, Antonia ^a   Grignaschi, Giuliano ^c   Volta, Manuela ^a   Moriggi, Manuela ^a   Daleno, Cristina ^c   Bendotti, Caterina ^c   Silani, Vincenzo ^a   Gelfi, Cecilia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CARBONATE DEHYDRATASE III; CITRATE SYNTHASE; CITRIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; ENOLASE BETA; FATTY ACID SYNTHASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; I KAPPA B ALPHA; MICROTUBULE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN LC3B; PROTEIN NDUFS1; PROTEIN NDUFV2; PROTEIN SDHA; PYRUVATE KINASE M2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RHO ASSOCIATED PROTEIN KINASE 1; SEMAPHORIN 3A; SUCCINATE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR RELA; TRANSFERRIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AEROBIC METABOLISM; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL METABOLISM; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DISEASE MARKER; DOWN REGULATION; ENZYMATIC ASSAY; ENZYME INACTIVATION; FEMALE; FORELIMB; GASTROCNEMIUS MUSCLE; HINDLIMB; HOMEOSTASIS; HYPERMETABOLISM; LIPID PEROXIDATION; MOUSE; MUSCLE ATROPHY; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RESPIRATORY CHAIN; TRICEPS BRACHII MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CITRATE (SI)-SYNTHASE; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; FEMALE; FORELIMB; HINDLIMB; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASE; PPAR GAMMA; PROTEOMICS; REACTIVE OXYGEN SPECIES; RHO-ASSOCIATED KINASES; SEMAPHORIN-3A; SUPEROXIDE DISMUTASE; TRANS-ACTIVATORS;

EID: 84866306094     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4524     Document Type: Article

References (69)

1. Adhihetty PJ, Uguccioni G, Leick L, Hidalgo J, Pilegaard H, and Hood DA. The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. Am J Physiol Cell Physiol 297: C217-C225, 2009.
2. Amano M, Nakayama M, and Kaibuchi K. Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 67: 545-554, 2010.
3. Amanso AM, Debbas V, and Laurindo FR. Proteasome inhibition represses unfolded protein response and Nox4, sensitizing vascular cells to endoplasmic reticulum stressinduced death. PLoS One 6: e14591, 2011.
4. Atkin JD, Farg MA, Walker AK, McLean C, and Tomas D, Horne MK. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis 30: 400-407, 2008.
5. Azzouz M, Leclerc N, Gurney M, Warter JM, Poindron P, and Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve 20: 45-51, 1997. (Pubitemid 27009468)
6. Barrett EF, Barrett JN, and David G. Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS. J Bioenerg Biomembr 43: 581-586, 2011.
7. Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, Silani V, and De Biasi S. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci 191: 25-33, 2001. (Pubitemid 33035892)
8. Bendotti C and Carri MT. Lessons from models of SOD1-linked familial ALS. Trends Mol Med 10: 393-400, 2004. (Pubitemid 39061141)
9. Bergemalm D, Forsberg K, Jonsson PA, Graffmo KS, Brannstrom T, Andersen PM, Antti H, and Marklund SL. Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential ingel electrophoresis. Mol Cell Proteomics 8: 1306-1317, 2009.
10. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, and Couratier P. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256: 1236-1242, 2009.
11. Calabrese V. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis". Free Radic Biol Med 43: 160-162, 2007. (Pubitemid 46977162)
12. Capitanio D, Vasso M, Fania C, Moriggi M, Vigano A, Procacci P, Magnaghi V, and Gelfi C. Comparative proteomic profile of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE. Proteomics 9: 2004-2020, 2009.
13. Carri MT, Ferri A, Cozzolino M, Calabrese L, and Rotilio G. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61: 365-374, 2003. (Pubitemid 36945467)
14. Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, and Gurney ME. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6: 349-362, 1995.
15. Crugnola V, Lamperti C, Lucchini V, Ronchi D, Peverelli L, Prelle A, Sciacco M, Bordoni A, Fassone E, Fortunato F, Corti S, Silani V, Bresolin N, Di Mauro S, Comi GP, and Moggio M. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol 67: 849-854, 2010.
16. Cutler RG, Pedersen WA, Camandola S, Rothstein JD, and Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52: 448-457, 2002.
17. Danieli Betto D, Zerbato E, and Betto R. Type 1, 2A, and 2B myosin heavy chain electrophoretic analysis of rat muscle fibers. Biochem Biophys Res Commun 138: 981-987, 1986. (Pubitemid 16013228)
18. De Winter F, Vo T, Stam FJ, Wisman LA, Bar PR, Niclou SP, van Muiswinkel FL, and Verhaagen J. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 32: 102-117, 2006. (Pubitemid 43868100)
19. Dupont-Versteegden EE, Kitten AM, Katz MS, and McCarter RJ. Elevated levels of albumin in soleus and diaphragm muscles of mdx mice. Proc Soc Exp BiolMed 213: 281-286, 1996.
20. Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F, Oudart H, Halter B, Huze C, Schaeffer L, Bouillaud F, and Loeffler JP. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 4: e5390, 2009.
21. Dupuis L and Loeffler JP. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol 9: 341-346, 2009.
22. Espinoza DO, Boros LG, Crunkhorn S, Gami H, and Patti ME. Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-activated receptor-gamma coactivator-1alpha and-1beta in cultured myotubes. FASEB J 24: 1003-1014, 2010.
23. Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, Rene F, Hocquette JF, Meininger V, Dupuis L, and Loeffler JP. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 48: 1571-1580, 2007. (Pubitemid 47312018)
24. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, and Glass JD. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185: 232-240, 2004. (Pubitemid 38084849)
25. Frey D, Schneider C, Xu L, Borg J, Spooren W, and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20: 2534-2542, 2000. (Pubitemid 30220340)
26. Gonzalez de Aguilar JL, Niederhauser-Wiederkehr C, Halter B, De Tapia M, Di Scala F, Demougin P, Dupuis L, Primig M, Meininger V, and Loeffler JP. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 32: 207-218, 2008. (Pubitemid 351186328)
27. Goto JJ, Zhu H, Sanchez RJ, Nersissian A, Gralla EB, Valentine JS, and Cabelli DE. Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem 275: 1007-1014, 2000. (Pubitemid 30051147)
28. Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, and Oppenheim RW. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 26: 8774-8786, 2006. (Pubitemid 44319413)
29. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775, 1994. (Pubitemid 24227760)
30. Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, and Spiegelman BM. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev 21: 770-783, 2007. (Pubitemid 46572357)
31. Hosono Y, Yamaguchi T, Mizutani E, Yanagisawa K, Arima C, Tomida S, Shimada Y, Hiraoka M, Kato S, Yokoi K, Suzuki M, and Takahashi T. MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J 31: 481-493, 2012.
32. Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, van den Heuvel LP, Wintjes LT, Stoltenborg-Hogenkamp BJ, and Rodenburg RJ. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 53: 729-734, 2007. (Pubitemid 46580245)
33. Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, and David S. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 29: 610-619, 2009.
34. Kolsch V, Charest PG, and Firtel RA. The regulation of cell motility and chemotaxis by phospholipid signaling. J Cell Sci 121: 551-559, 2008. (Pubitemid 351524153)
35. Lee AH, Scapa EF, Cohen DE, and Glimcher LH. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320: 1492-1496, 2008. (Pubitemid 351929428)
36. Lelie HL, Liba A, Bourassa MW, Chattopadhyay M, Chan PK, Gralla EB, Miller LM, Borchelt DR, Valentine JS, and Whitelegge JP. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J Biol Chem 286: 2795-2806, 2011.
37. Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, Chun SJ, Roy T, Winer L, Yates JR, Capaldi RA, Cleveland DW, and Miller TM. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci USA 107: 21146-21151, 2010.
38. Liang H, Ward WF, Jang YC, Bhattacharya A, Bokov AF, Li Y, Jernigan A, Richardson A, and Van Remmen H. PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve 44: 947-956, 2011.
39. Liochev SI and Fridovich I. Copper, zinc superoxide dismutase and H2O2. Effects of bicarbonate on inactivation and oxidations of NADPH and urate, and on consumption of H2O2. J Biol Chem 277: 34674-34678, 2002.
40. Lukas TJ, Luo WW, Mao H, Cole N, and Siddique T. Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis. Mol Cell Proteomics 5: 1233-1244, 2006. (Pubitemid 44103395)
41. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-898, 1999. (Pubitemid 29381991)
42. Massignan T, Casoni F, Basso M, Stefanazzi P, Biasini E, Tortarolo M, Salmona M, Gianazza E, Bendotti C, and Bonetto V. Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun 353: 719-725, 2007. (Pubitemid 46048729)
43. Maurer MH. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom Rev 29: 17-28, 2010.
44. Menendez JA. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives. Biochim Biophys Acta 1801: 381-391, 2010.
45. Munujos P, Coll-Canti J, Gonzalez-Sastre F, and Gella FJ. Assay of succinate dehydrogenase activity by a colorimetriccontinuous method using iodonitrotetrazolium chloride as electron acceptor. Anal Biochem 212: 506-509, 1993. (Pubitemid 23245103)
46. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
47. Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH, Jr., and Itoyama Y. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21: 9246-9254, 2001. (Pubitemid 33096868)
48. Napoli L, Crugnola V, Lamperti C, Silani V, Di Mauro S, Bresolin N, and Moggio M. Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. Arch Neurol 68: 1612-1613, 2011.
49. Narumiya S, Ishizaki T, and Watanabe N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett 410: 68-72, 1997. (Pubitemid 27283386)
50. Nassif M, Matus S, Castillo K, and Hetz C. Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway. Antioxid Redox Signal 13: 1955-1989, 2010.
51. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, and Ho L. Identification of potential CSF biomarkers in ALS. Neurology 66: 1218-1222, 2006. (Pubitemid 43739707)
52. Pasterkamp RJ and Giger RJ. Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 19: 263-274, 2009.
53. Poon HF, Hensley K, Thongboonkerd V, Merchant ML, Lynn BC, Pierce WM, Klein JB, Calabrese V, and Butterfield DA. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 39: 453-462, 2005. (Pubitemid 41021644)
54. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993. (Pubitemid 23087289)
55. Rosser BW, Norris BJ, and Nemeth PM. Metabolic capacity of individual muscle fibers from different anatomic locations. J Histochem Cytochem 40: 819-825, 1992.
56. Rowe GC, Jiang A, and Arany Z. PGC-1 coactivators in cardiac development and disease. Circ Res 107: 825-838, 2010.
57. Sadrzadeh SM and Saffari Y. Iron and brain disorders. Am J Clin Pathol 121 Suppl: S64-S70, 2004.
58. Sahawneh MA, Ricart KC, Roberts BR, Bomben VC, Basso M, Ye Y, Sahawneh J, Franco MC, Beckman JS, and Estevez AG. Cu, Zn-superoxide dismutase increases toxicity of mutant and zinc-deficient superoxide dismutase by enhancing protein stability. J Biol Chem 285: 33885-33897, 2010.
59. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, and Spiegelman BM. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103: 16260-16265, 2006. (Pubitemid 44715184)
60. Sasaki AT and Firtel RA. Regulation of chemotaxis by the orchestrated activation of Ras, PI3K, and TOR. Eur J Cell Biol 85: 873-895, 2006. (Pubitemid 44334734)
61. Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, and Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol 39: 203-216, 1996. (Pubitemid 26071571)
62. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, and Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397-408, 2006. (Pubitemid 44572377)
63. Strong M and Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 4: 136-143, 2003. (Pubitemid 37184881)
64. Summermatter S, Baum O, Santos G, Hoppeler H, and Handschin C. Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. J Biol Chem 285: 32793-32800, 2010.
65. Tolias KF, Duman JG, and Um K. Control of synapse development and plasticity by Rho GTPase regulatory proteins. Prog Neurobiol 94: 133-148, 2011.
66. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, and Julien JP. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9: 108-118, 2006. (Pubitemid 43011916)
67. Vigano A, Vasso M, Caretti A, Bravata V, Terraneo L, Fania C, Capitanio D, Samaja M, and Gelfi C. Protein modulation in mouse heart under acute and chronic hypoxia. Proteomics 11: 4202-4217, 2011.
68. Wijesekera LC and Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4: 3, 2009.
69. Zhang H, Andrekopoulos C, Joseph J, Chandran K, Karoui H, Crow JP, and Kalyanaraman B. Bicarbonate-dependent peroxidase activity of human Cu, Zn-superoxide dismutase induces covalent aggregation of protein: intermediacy of tryptophan-derived oxidation products. J Biol Chem 278: 24078-24089, 2003. (Pubitemid 36830241)